...
首页> 外文期刊>Cancer Management and Research >miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA
【24h】

miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA

机译:miR-125a-5p通过靶向VEGFA抑制大肠癌进展

获取原文

摘要

Background: MiR-125a-5p has been reported to be involved in the development and progression of various cancers. However, the biological function and underlying mechanisms in colorectal cancer(CRC) still remain unclear. Here, we explored the potential biological roles of miR-125a-5p in CRC. Methods: The expression of miR-125a-5p was detected using quantitative real-time PCR (qRT-PCR), biological functions of miR-125a-5p were assessed by cell counting kit-8, wound-healing, transwell invasion, and human umbilical vein endothelial cell (HUVEC) tube formation assays in vitro and animal experiments in vivo. Results: We found that miR-125a-5p was downregulated in CRC tissues and cell lines, it inhibited CRC cell proliferation, migration, and invasion and reduced the ability of HUVECs to form tubes. Moreover, we verifed that miR-125a-5p suppressed CRC growth and metastasis in vivo. Additionally, we showed that VEGFA, a direct target gene of miR-125a-5p, could reverse the inhibitory effect caused by miR-125a-5p overexpression. Conclusion: miR-125a-5p might serve as a tumor suppressor in CRC and could be regarded as a potential therapeutic candidate for CRC.
机译:背景:据报道,MiR-125a-5p与各种癌症的发生和发展有关。然而,大肠癌的生物学功能和潜在机制仍不清楚。在这里,我们探讨了miR-125a-5p在CRC中的潜在生物学作用。方法:采用定量实时荧光定量PCR(qRT-PCR)检测miR-125a-5p的表达,用细胞计数试剂盒8,伤口愈合,穿透孔侵袭和人类检测miR-125a-5p的生物学功能。体外脐静脉内皮细胞(HUVEC)管形成测定和体内动物实验。结果:我们发现miR-125a-5p在CRC组织和细胞系中下调,抑制CRC细胞的增殖,迁移和侵袭,并降低HUVEC形成管的能力。此外,我们验证了miR-125a-5p在体内抑制CRC的生长和转移。此外,我们表明VEGFA是miR-125a-5p的直接靶基因,可以逆转miR-125a-5p过表达引起的抑制作用。结论:miR-125a-5p可能在CRC中起着抑癌作用,被认为是CRC的潜在治疗候选物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号